Rilpivirine versus efavirenz with emtricitabine/tenofovir disoproxil fumarate in treatment-naïve HIV-1-infected patients with HIV-1 RNA ≤100,000 copies/mL: week 96 pooled ECHO/THRIVE subanalysis (Q37701095)
Jump to navigation
Jump to search
scientific article published on 24 March 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Rilpivirine versus efavirenz with emtricitabine/tenofovir disoproxil fumarate in treatment-naïve HIV-1-infected patients with HIV-1 RNA ≤100,000 copies/mL: week 96 pooled ECHO/THRIVE subanalysis |
scientific article published on 24 March 2014 |
Statements
Rilpivirine versus efavirenz with emtricitabine/tenofovir disoproxil fumarate in treatment-naïve HIV-1-infected patients with HIV-1 RNA ≤100,000 copies/mL: week 96 pooled ECHO/THRIVE subanalysis (English)
Georg Behrens
Mark Nelson
Calvin Cohen
Richard A Elion
Simon Vanveggel
Marita Stevens
Laurence Rimsky
David Thorpe
Matthew Bosse
Kirsten White
Lijie Zhong
Jennifer DeMorin
Susan K Chuck